The role of molecular imaging in the evaluation of myocardial and peripheral angiogenesis

Annals of Nuclear Medicine

Volumn 29, Issue 3, 2015, Pages 217-223

  Stacy, Mitchel R ^a   Paeng, Jin Chul ^b   Sinusas, Albert J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Seoul National University Hospital   (South Korea)

Author keywords

Molecular imaging; Myocardial angiogenesis; Peripheral angiogenesis; PET; SPECT

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

ANIMAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; ISCHEMIA; LIMB; MOLECULAR IMAGING; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; PATHOPHYSIOLOGY; PROCEDURES; SCINTISCANNING;

ANIMALS; EXTREMITIES; HUMANS; ISCHEMIA; MOLECULAR IMAGING; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 84939947277     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-015-0961-y     Document Type: Article

References (48)

1. Stacy MR, Sinusas AJ. Emerging imaging modalities in regenerative medicine. Curr Pathobiol Rep. 2015;3:27–36.
2. Stacy MR, Zhou W, Sinusas AJ. Radiotracer imaging of peripheral vascular disease. J Nucl Med. 2013;54:2104–10.
3. Cal-Gonzalez J, Lage E, Herranz E, Vicente E, Udias JM, Moore SC, et al. Simulation of triple coincidences in PET. Phys Med Biol. 2015;60:117–36.
4. Andreyev A, Celler A. Dual-isotope PET using positron-gamma emitters. Phys Med Biol. 2011;56:4539–56.
5. Stacy MR, Maxfield MW, Sinusas AJ. Targeted molecular imaging of angiogenesis in PET and SPECT: a review. Yale J Biol Med. 2012;85:75–86.
6. Hong H, Chen F, Zhang Y, Cai W. New radiotracers for imaging of vascular targets in angiogenesis-related diseases. Adv Drug Deliv Rev. 2014;76:2–20.
7. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843–5.
8. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, et al. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest. 1996;97:469–76.
9. Banai S, Jaklitsch MT, Shou M, Lazarous DF, Scheinowitz M, Biro S, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation. 1994;89:2183–9.
10. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996;270:H1803–11.
11. Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene. 2008;27:5132–7.
12. Eichmann A, Simons M. VEFG signaling inside vascular endothelial cells and beyond. Curr Opin Cell Biol. 2012;24:188–93.
13. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Ann Rev Cell Dev Biol. 1995;11:549–99.
14. Cai W, Guzman R, Hsu AR, Wang H, Chen K, Sun G, et al. Positron emission tomography imaging of poststroke angiogenesis. Stroke. 2009;40:270–7.
15. Choi H, Phi JH, Paeng JC, Kim SK, Lee YS, Jeong JM, et al. Imaging of integrin a(V)B(3) expression using (68)Ga-RGD positron emission tomography in pediatric cerebral infarct. Mol Imaging. 2013;12:213–7.
16. Kalinowski L, Dobrucki LW, Meoli DF, Dione DP, Sadeghi MM, Madri JA, et al. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction. J Appl Physiol. 2008;104:1504–12.
17. Dimastromatteo J, Riou LM, Ahmadi M, Pons G, Pellegrini E, Broisat A, et al. In vivo molecular imaging of myocardial angiogenesis using the alpha(v)beta3 integrin-targeted tracer 99mTc-RAFT-RGD. J Nucl Cardiol. 2010;17:435–43.
18. Gao H, Lang L, Guo N, Cao F, Quan Q, Hu S, et al. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AIF-NOTA-PRGD2. Eur J Nucl Med Mol Imaging. 2012;39:683–92.
19. Eo JS, Paeng JC, Lee S, Lee YS, Jeong JM, Kang KW, et al. Angiogenesis imaging in myocardial infarction using 68 Ga-NOTA-RGD PET: characterization and application to therapeutic efficacy monitoring in rats. Coron Artery Dis. 2013;24:303–11.
20. Menichetti L, Kusmic C, Panetta D, Arosio D, Petroni D, Matteucci M, et al. MicroPET/CT imaging of alpha(v)beta(3) integrin via a novel (68)Ga-NOTA-RGD peptidomimetic conjugate in rat myocardial infarction. Eur J Nucl Med Mol Imaging. 2013;40:1265–74.
21. Meoli DF, Sadeghi MM, Krassilnikova S, Bourke BN, Giordano FJ, Dione DP, et al. Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest. 2004;113:1684–91.
22. Dobrucki LW, Meoli DF, Hu J, Sadeghi MM, Sinusas AJ. Regional hypoxia correlates with the uptake of a radiolabeled targeted marker of angiogenesis in rat model of myocardial hypertrophy and ischemic injury. J Physiol Pharmacol. 2009;60:117–23.
23. Paeng JC, Bregasi A, Sahul Z, Kalinowski L, Dobrucki LW, Brennan M, et al. Serial reference tissue-based quantitative and volumetric analysis of integrin-targeted angiogenesis imaging: chronic canine model of myocardial infarction. J Nucl Med. 2014;55:1710.
24. Higuchi T, Bengel FM, Seidl S, Watzlowik P, Kessler H, Hegenloh R, et al. Assessment of alphavbeta3 integrin expression after myocardial infarction by positron emission tomography. Cardiovasc Res. 2008;78:395–403.
25. Makowski MR, Ebersberger U, Nekolla S, Schwaiger M. In vivo molecular imaging of angiogenesis, targeting alphavbeta3 integrin expression, in a patient after acute myocardial infarction. Eur Hear. J. 2008;29:2201.
26. Rodriguez-Porcel M, Cai W, Gheysens O, Willmann JK, Chen K, Wang H, et al. Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med. 2008;49:667–73.
27. Orbay H, Zhang Y, Valdovinos HF, Song G, Hernandez R, Theuer CP, et al. Positron emission tomography imaging of CD105 expression in a rat myocardial infarction model with (64)Cu-NOTA-TRC105. Am J Nucl Med Mol Imaging. 2013;4:1–9.
28. Sun Y, Zeng Y, Zhu Y, Feng F, Xu W, Wu C, et al. Application of (68)Ga-PRGD2 PET/CT for alpha(v)beta(3)-integrin imaging of myocardial infarction and stroke. Theranostics. 2014;4:778–86.
29. Laitinen I, Notni J, Pohle K, Rudelius M, Farrell E, Nekolla SG, et al. Comparison of cyclic RGD peptides for alpha(v)beta(3) integrin detection in a rat model of myocardial infarction. EJNMMI Res. 2013;3:38.
30. Johnson LL, Schofield L, Donahay T, Bouchard M, Poppas A, Haubner R. Radiolabeled arginine-glycine-aspartic acid peptides to image angiogenesis in swine model of hibernating myocardium. JACC Cardiovasc Imaging. 2008;1:500–10.
31. Dobrucki L, Tsutsumi Y, Kalinowski L, Dean J, Gavin M, Sen S, et al. Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. J Mol Cell Cardiol. 2010;48:1071–9.
32. Cocker MS, Dwivedi G, Marvin B, Poirier M, Dennie C, Wells G, et al. Integrin imaging for the detection of diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy: direct comparison between single-photon emission computed tomography and cardiovascular magnetic resonance. The SCAR study. Am Hear Assoc Sci Sess. 2012;A19661.
33. Mozid AM, Holstensson M, Choudhury T, Ben-Haim S, Allie R, Martin J, et al. Clinical feasibility study to detect angiogenesis following bone marrow stem cell transplantation in chronic ischaemic heart failure. Nucl Med Commun. 2014;35:839–48.
34. Orbay H, Hong H, Koch JM, Valdovinos HF, Hacker TA, Theuer CP, et al. Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with (64)Cu-NOTA-TRC105. Am J Transl Res. 2013;6:54–63.
35. Almutairi A, Rossin R, Shokeen M, Hagooly A, Ananth A, Capoccia B, et al. Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci USA. 2009;106:685–90.
36. Dobrucki LW, Dione DP, Kalinowski L, Dione D, Mendizabal M, Yu J, et al. Serial noninvasive targeted imaging of peripheral angiogenesis: validation and application of a semiautomated quantitative approach. J Nucl Med. 2009;50:1356–63.
37. Lu E, Wagner WR, Schellenberger U, Abraham JA, Klibanov AL, Woulfe SR, et al. Targeted in vivo labeling of receptors for vascular endothelial growth factor: approach to identification of ischemic tissue. Circulation. 2003;108:97–103.
38. Stacy MR, Yu DY, Maxfield MW, Jaba IM, Jozwik BP, Zhuang ZW, et al. Multimodality imaging approach for serial assessment of regional changes in lower extremity arteriogenesis and tissue perfusion in a porcine model of peripheral arterial disease. Circ Cardiovasc Imaging. 2014;7:92–9.
39. Lee K, Jung K, Song S, Kim DH, Lee BC, Sung HJ, et al. Radiolabeled RGD uptake and alpha(v) integrin expression is enhanced in ischemic murine hindlimbs. J Nucl Med. 2005;46:472–8.
40. Hua J, Dobrucki LW, Sadeghi MM, Zhang J, Bourke BN, Cavaliere P, et al. Noninvasive imaging of angiogenesis with a (99 m)Tc-labeled peptide targeted at alpha(v)beta(3) integrin after murine hindlimb ischemia. Circulation. 2005;111:3255–60.
41. Jeong JM, Hong MK, Chang YS, Lee Y-S, Kim YJ, Cheon GJ, et al. Preparation of a promising anigogenesis PET imaging agent: (68)Ga-labeled c(RGDyK)-isothiocyanatobenzyl1-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med. 2008;49:830–6.
42. Willmann JK, Chen K, Wang H, Paulmurugan R, Rollins M, Cai W, et al. Monitoring of the biological response to murine hindlimb ischemia with 64Cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation. 2008;117:915–22.
43. Liu Y, Pressly ED, Abendschein DR, Hawker CJ, Woodard GE, Woodard PK, et al. Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PET. J Nucl Med. 2011;52:1956–63.
44. Li S, Sinusas AJ, Dobrucki LW, Liu YH. New approach to quantification of molecularly targeted radiotracer uptake from hybrid cardiac SPECT/CT: methodology and validation. J Nucl Med. 2013;54:2175–81.
45. Lindsey ML, Escobar GP, Dobrucki LW, Goshorn DK, Bouges S, Mingoia JT, et al. Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction. Am J Physiol Hear Circ Physiol. 2006;290:H232–9.
46. Orbay H, Zhang Y, Hong H, Hacker TA, Valdovinos HF, Zagzebski JA, et al. Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with (64)Cu-labeled TRC105. Mol Pharm. 2013;10:2749–56.
47. Mehra VC, Jackson E, Zhang XM, Jiang XC, Dobrucki LW, Yu J, et al. Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis. Am J Pathol. 2014;184:1562–76.
48. Hedhli N, Dobrucki LW, Kalinowski A, Zhuang ZW, Wu X, Russell RR 3rd, et al. Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesis. Cardiovasc Res. 2012;93:516–24.